Air-purifying church windows early nano...(s very energy efficient because only the...)
Navigation Links
Air-purifying church windows early nanotechnology
Date:8/21/2008
s very energy efficient, because only the particles of gold heat up," he said.
"In conventional chemical reactions, you heat up everything, which is a waste of energy.
"Once this technology can be applied to produce specialty chemicals at ambient temperature, it heralds significant changes in the economy and environmental impact of the chemical production."
'/>"/>
| Contact: Rachael Wilson rachael.wilson@qut.edu.au Queensland University of Technology Source:Eurekalert |
Related biology news :
1. Futronic Announces Microsoft Vista and Windows 2008 Server Support for Its Fingerprint Logon Software
2. 60 second test could help early diagnosis of common brain diseases
3. Restless legs syndrome affects nearly 2 percent of US/UK children
4. Bleeding, not inflammation, is major cause of early lung infection death
5. Pig study sheds new light on the colonisation of Europe by early farmers
6. Color contrast is seen by the brain early doors
7. Extra gene copies were enough to make early humans mouths water
8. Was ability to run early mans Achilles heel?
9. New technique can be breakthrough for early cancer diagnosis
10. Yam bean a nearly forgotten crop
11. NIH awards nearly $23M to University of Chicago for translational research
Post Your Comments:
Related Image:
 Air-purifying church windows early nanotechnology |
Breaking Biology News(10 mins):Brooding fishes take up nutrients from their own children 2Researchers finds hidden sensory system in the skin 2Researchers finds hidden sensory system in the skin 3Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2Injury and hazards in home health care nursing are a growing concern 59078 1Injury and hazards in home health care nursing are a growing concern 59078 2Injury and hazards in home health care nursing are a growing concern 59078 3American Association for Cancer Research to honor leading researchers at breast cancer symposium 10288 1American Association for Cancer Research to honor leading researchers at breast cancer symposium 10288 2Birth Control Pills Might Alter Mate Selection 3A Study 59074 1Birth Control Pills Might Alter Mate Selection 3A Study 59074 2Birth Control Pills Might Alter Mate Selection 3A Study 59074 3
Other Biology News:Attention shoppers: Researchers find neurons that encode the value of different goods 2Attention shoppers: Researchers find neurons that encode the value of different goods 3Anthrax inhibitor counteracts toxin, may lead to new therapeutics 2Anthrax inhibitor counteracts toxin, may lead to new therapeutics 3The evolution of food plants: Genetic control of grass flower architecture 2
Breaking Biology Technology:CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3Dendreon Announces Proposed Public Offering of Common Stock 2Dendreon Announces Proposed Public Offering of Common Stock 3Reportlinker Adds Biotechnology Instrumentation - International Market Trends 2Reportlinker Adds Biotechnology Instrumentation - International Market Trends 3Reportlinker Adds Biotechnology Instrumentation - International Market Trends 4Reportlinker Adds Biotechnology Instrumentation - International Market Trends 5Reportlinker Adds Biotechnology Instrumentation - International Market Trends 6Reportlinker Adds Biotechnology Instrumentation - International Market Trends 7Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3
Other Biology Technology:Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years 2XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 2XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 3XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 4
Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five YearsXTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio PharmaceuticalsSGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |